Research Papers

25 of 153 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imag…
Kotha S; Plein S; Greenwood JP; Levelt E.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology…
Been RA; Lameijer A; Gans ROB; van Beek AP; Kingsnorth AP; Choudhary P; van Dijk PR.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Epidemiology of gout - Global burden of disease research from 1990 to 2019 and future trend predictions.
Han T; Chen W; Qiu X; Wang W.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review.
Kiconco R; Lumumba SA; Bagenda CN; Atwine R; Ndarubweine J; Rugera SP.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children's Hospital of Eastern Ontario g…
Sergi CM; Kehar M; Jimenez-Rivera C.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Anti-inflammatory role of glucagon-like peptide 1 receptor agonists and its clinical implications.
Alharbi SH.
Ther Adv Endocrinol Metab (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Assessing the prediction of type 2 diabetes risk using polygenic and clinical risk scores in South Asian study populati…
Rout M; Wander GS; Ralhan S; Singh JR; Aston CE; Blackett PR; Chernausek S; Sanghera DK.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone.
Giveon S; Zacay G; Vered I; Foldes AJ; Tripto-Shkolnik L.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Pheochromocytoma: a changing perspective and current concepts.
Kiriakopoulos A; Giannakis P; Menenakos E.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Exploring the mechanism of metformin action in Alzheimer's disease and type 2 diabetes based on network pharmacology, m…
Shi X; Li L; Liu Z; Wang F; Huang H.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Association of hyponatremia with bone mineral density and fractures: a narrative review.
Tzoulis P; Yavropoulou MP.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study.
Sun S; Chen L; Chen D; Li Y; Liu G; Ma L; Li J; Cao F; Ran X.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes.
Kattner N.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Patient-perceived benefits and risks of off-label use of SGLT2 inhibitors and GLP-1 receptor agonists in type 1 diabete…
Edwards K; Uruska A; Duda-Sobczak A; Zozulinska-Ziolkiewicz D; Lingvay I.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fractures and dislocations of the foot and ankle in people with diabetes: a literature review.
Johnson MJ; Kandasamy S; Raspovic KM; Manchanda K; Liu GT; VanPelt MD; Lavery LA; Wukich DK.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease.
Kulkarni AV; Sarin SK.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Implications of gender-affirming endocrine care for sports participation.
Moreland E; Cheung AS; Cheung AS; Hiam D; Nolan BJ; Landen S; Jacques M; Eynon N; Jones P.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD).
Tzoulis P; Kaltsas G; Baldeweg SE; Bouloux PM; Grossman AB.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse a…
Iwamoto SJ; Defreyne J; Kaoutzanis C; Davies RD; Moreau KL; Rothman MS.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke.
Barkas F; Anastasiou G; Liamis G; Milionis H.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Gender-affirming endocrine care for youth with a nonbinary gender identity.
Hodax JK; DiVall S.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Should we undertake surveillance for HCC in patients with MAFLD?
Norero B; Dufour JF.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fatty liver disease in children (MAFLD/PeFLD Type 2): unique classification considerations and challenges.
Hegarty R; Kyrana E; Fitzpatrick E; Dhawan A.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Non-pharmacological management options for MAFLD: a practical guide.
Stefano JT; Duarte SMB; Ribeiro Leite Altikes RG; Oliveira CP.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Tackling diabetic foot: limb salvage during the COVID-19 pandemic.
Schmidt BM; Shin L.
Ther Adv Endocrinol Metab (Unknown)
Published: 2023
3/6 Transparent
Funding Declared